Patients with atrial fibrillation receiving routine medical care within a large managed care organization were found to have suboptimal anticoagulation control. Retrospective cross-sectional study of ...

One direct-acting anticoagulant stands out as the least likely to cause dangerous bleeding in elderly patients with atrial fibrillation, according to a new study. But other new research questions the ...

It is uncommon for hospitalized older adults newly diagnosed with atrial fibrillation to start anticoagulation therapy. In fact, only about 25% overall begin taking these medications soon after ...

CHICAGO -- Researchers failed to prevent cognitive impairment in people with existing atrial fibrillation (Afib) by going the route of anticoagulation to mitigate subclinical brain infarcts, according ...

Apixaban (Eliquis) was associated with lower serious bleeding rates than rivaroxaban (Xarelto) or warfarin in patients with cirrhosis and atrial fibrillation (AF, Afib) in a nationwide cohort study.

For patients who are scheduled for surgery, warfarin therapy should be discontinued 5 to 6 days before the procedure. 26 In patients who are at high risk for developing blood clots, the clinician may ...

ATLANTA, Georgia — Patients with atrial fibrillation receiving anticoagulant therapy are more likely to experience gastrointestinal (GI) bleeding when treated with rivaroxaban than when treated with ...

Blood thinners (anticoagulants) cause bleeding without preventing stroke in patients with atrial high rate episodes (AHRE), but without electrocardiogram (ECG)-diagnosed atrial fibrillation, according ...

Background: There are a variety of periprocedural anticoagulation strategies for atrial fibrillation (AF) ablation, including the use of dabigatran. It is unclear which strategy is superior. Objective ...

Please provide your email address to receive an email when new articles are posted on . Data show early anticoagulation after acute stroke in people with atrial fibrillation is safe when indicated.

Atrial fibrillation (AF) is a prevalent cardiac arrhythmia that significantly elevates the risk of thromboembolic events, most notably ischaemic stroke. Anticoagulation therapy has long been a ...